This week's issue of Science carries a letter from IBM presenting its side of an ongoing controversy triggered when an occupational medicine journal refused to publish a study reporting high cancer mortality in workers at the computer firm's semiconductor plants.
Last month, other researchers who were slated to contribute to a November issue of Clinics in Occupational and Environmental Medicine withdrew their submissions in protest over the Elsevier publication's refusal to include the article by Richard Clapp.
IBM spokesperson Chris Andrews told